BUZZ-Ebola drug developers: Up after U.S. confirms first case

Tue Sep 30, 2014 5:27pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian drugmaker Tekmira Pharmaceutical's U.S.-listed shares up 19 pct at $25.25 in extended trading

** BioCryst's shares up 19 pct at $11.60; Sarepta Therapeutics up 4 pct at $22.00; Newlink Genetics Corp up 17 pct at $25.01

** All companies have potential Ebola treatments

** U.S. health officials said on Tuesday the first patient had been diagnosed with the deadly Ebola virus in the country

** The U.S. Centers for Disease Control and Prevention confirmed the diagnosis

** No additional details were immediately available